logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Life Science
Filter

Life Science

Categories

Sectors

Locations

Exchange

Healthcare Roundup – G1 Therapeutics jumps 16.9% as trilaciclib wins FDA approval; Bionano Genomics shares hit all-time high, spiking nearly 23%

Feb 12, 2021

Life Science

Healthcare Roundup – Merck and Teva in talks to join COVID-19 vaccine production, Aurora Cannabis shares up after FQ2 revenue rides high on medical cannabis strength

Feb 11, 2021

Life Science

HempFusion PR

HempFusion Launches Sleep and Stress Products With Twice the Amount of CBD

Feb 11, 2021

Life Science

Healthcare Roundup – Generex announces receipt of $2M for its COVID-19 vaccine development; I-Mab’s cancer therapy greenlighted in China for phase 1 trial

Feb 10, 2021

Life Science

医疗保健精选——百时美施贵宝宣布Opdivo/Cabometyx组合治疗肾癌的最新后期数据;默克抗病毒molnupiravir有效预防肺组织中的COVID-19

Healthcare Roundup – Bristol Myers announce new late-stage data for Opdivo/ Cabometyx combo in kidney cancer; Merck antiviral molnupiravir effective in preventing COVID-19 in lung tissue

Feb 10, 2021

Life Science

HempFusion PR

HempFusion’s Chief Marketing Officer, Ms. Ola Lessard, Elected President of The U.S. Hemp Roundtable for Second Consecutive Term

Feb 9, 2021

Life Science

医疗保健精选——百时美施贵宝的Inrebic获得欧盟委员会批准;辉瑞/BioNTech将向欧盟供应的疫苗增加一倍

Healthcare Roundup – Bristol Myers Squibb’s Inrebic nabs European Commission approval; Pfizer/BioNTech double the vaccine supply to EU

Feb 8, 2021

Life Science

医疗保健精选——Clover Health股价收盘上涨近6%;百时美施贵宝淋巴瘤疗法Breyanzi获得批准

Healthcare Roundup – Clover shares close up nearly 6% after Chamath Palihapitiya rebukes Hindenburg report; Bristol Myers Squibb wins FDA approval for lymphoma treatment Breyanzi

Feb 5, 2021

Life Science

Healthcare Roundup – Omega Health buys 24 facilities for $510M; Align Tech up 13% as analysts view Q4 2020 results favorably

Feb 4, 2021

Life Science

医疗保健精选--Jazz将通过现金和股票交易收购GW Pharma;Cassava Sciences取得阿尔茨海默病治疗的积极试验数据后股价上涨

Healthcare Roundup – Jazz to acquire GW Pharma in cash-and-stock deal valued at $7.2B; Anavex gains after favorable data from Cassava Sciences in Alzheimer’s

Feb 4, 2021

Life Science

HempFusion PR

HempFusion Announces US Symbol, CBDHF

Feb 3, 2021

Life Science

医疗保健精选——辉瑞公司有望5月前向美国供应2亿剂新冠疫苗;Cassava的阿尔茨海默病试验得出积极数据

Healthcare Roundup – Pfizer runs early on schedule to supply 200M COVID vaccine doses to U.S. by May; Cassava surges after favorable trial data for simufilam in Alzheimer’s disease

Feb 3, 2021

Life Science

HempFusion PR

HempFusion Wellness Inc. Becomes Exclusive CBD and Probiotics Sponsor of Loenbro Motorsports for 2021 Racing Season

Feb 2, 2021

Life Science

医疗保健 healthcare

Healthcare Roundup – Illumina surges after patent win; announces collaboration in China; BioCryst climbs after being named ‘the most undervalued stock in the market

Feb 1, 2021

Life Science

医疗保健精选——阿斯利康新冠疫苗获欧洲批准;eHealth宣布获得2.25亿美元战略投资

Healthcare Roundup – AstraZeneca gets European nod for COVID-19 vaccine; eHealth announces $225M strategic investment from H.I.G. capital

Jan 30, 2021

Life Science

医疗保健精选——阿斯利康COVID-19注射液仅适用于德国18-64岁人群;Hims & Hers Health大涨

Healthcare Roundup – AstraZeneca COVID-19 shot is only for those aged 18-64 in Germany, Hims & Hers Health soars after Cathie Wood’s ETF discloses stake

Jan 28, 2021

Life Science

HempFusion PR

HempFusion Wellness Inc. Launches Probulin Total Care Immune Probiotic for National Distribution

Jan 28, 2021

Life Science

医疗保健精选——辉瑞的挫折可能会伤害到其他JAK抑制剂,EyePointe股价上涨

Healthcare Roundup – Pfizer’s setback can hurt others with JAK inhibitors, EyePoint surges after Cantor Fitzgerald nod; potential of EYP-1901 cited

Jan 27, 2021

Life Science

  • ‹‹ Previous
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada